The popularity of Viagra initially sparked a surge for major pharmaceutical companies, but recent shifts present a uncertain picture for investors. Off-patent versions are eroding revenue, and ongoing patent challenges https://jasonxiwb985856.isblog.net/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-investment-58493299